ECHO Trademark

Trademark Overview


On Tuesday, October 21, 2025, a trademark application was filed for ECHO with the United States Patent and Trademark Office. The USPTO has given the ECHO trademark a serial number of 79441998. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, January 22, 2026. This trademark is owned by Celyntra Therapeutics SA. The ECHO trademark is filed in the Treatment & Processing of Materials Services and Computer & Software Services & Scientific Services categories with the following description:

Scientific research, design and technological development services in the fields of scientific iPSC-based cell cultures, iPSC-based cell therapies, and iPSC-based gene-edited cell therapy; scientific research, design and development of manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to iPSC-based cell culture, iPSC-based cell therapy, or iPSC-based gene edited cell therapy manufacturing.

Custom manufacture of therapeutic iPSC-based cells, iPSC-based cells for use in cell therapies and iPSC-based allogeneic edited cells for use in therapies, for others; custom manufacture of iPSC-based allogeneic cells for use in cell therapies.
echo

General Information


Serial Number79441998
Word MarkECHO
Filing DateTuesday, October 21, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, January 22, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesScientific research, design and technological development services in the fields of scientific iPSC-based cell cultures, iPSC-based cell therapies, and iPSC-based gene-edited cell therapy; scientific research, design and development of manufacturing processes in the fields of cell culture, cell therapy, and gene edited cell therapy, for others; scientific consultation services in the field of biotechnology, specifically in relation to iPSC-based cell culture, iPSC-based cell therapy, or iPSC-based gene edited cell therapy manufacturing.
Goods and ServicesCustom manufacture of therapeutic iPSC-based cells, iPSC-based cells for use in cell therapies and iPSC-based allogeneic edited cells for use in therapies, for others; custom manufacture of iPSC-based allogeneic cells for use in cell therapies.

Classification Information


International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateThursday, January 22, 2026
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 22, 2026
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCelyntra Therapeutics SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressBE

Trademark Events


Event DateEvent Description
Thursday, January 22, 2026SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, January 27, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 27, 2026APPLICATION FILING RECEIPT MAILED